• News
  • Inquiry
  • Contact Us for business opportunity
  • Recruitment information
  • Japanese
  • HOME
  • Vision
    Vision
    Introducing the vision SymBio Pharmaceuticals.
    • CEO message
      CEO message
    • SymBio in 2 minutes
      SymBio in 2 minutes
    • Corporate culture
      Corporate culture
    • Charter of Corporate Behavior
      Charter of Corporate Behavior
    • Book introduction
      Book introduction
  • Business model
    Business model
    I would like to introduce the business model of SymBio Pharmaceuticals.
    • Business domain and profit model
      Business domain and profit model
    • Proprietary drug discovery business
      Proprietary drug discovery business
    • Global business
      Global business
    • Joint research with academia
      Joint research with academia
    • Key person interview
      Key person interview
  • Pipeline
    Pipeline
    We would like to introduce the pipeline of SymBio Pharmaceuticals.
    • Pipeline overview
      Pipeline overview
    • SyB V-1901
      SyB V-1901
    • SyB L-0501
      SyB L-0501
  • IR information
    IR information
    Aiming for patient-centered, mutually supportive relationships among scientists, doctors, governments, and shareholders.
    • Latest IR information
      Latest IR information
    • IR news
      IR news
    • CEO message
      CEO message
    • Financial highlights
    • IR library
    • Analyst report
    • Video library
    • IR Calendar
    • General Meeting of Shareholders Information
    • Basic stock information
    • Electronic public notice
  • About SymBio
    About SymBio
    Company Information of SymBio Pharmaceuticals
    • Company Profile
      Company Profile
    • Origin of company name
      Origin of company name
    • History
      History
    • Officer introduction
    • Organization chart
    • Corporate
      governance
    • Compliance
      about
    • on transparency
      Information disclosure
    • SDGs initiatives
  • News
  • Inquiry
  • Recruitment of new drug information
  • Recruitment information
  • Japanese
  1. TOP
  2. IR information
  3. Annual Report

Annual Report

  • Summary of Financial Results
  • Business Results
  • 株主通信 (Japanese Only)
  • 有価証券報告書・四半期報告書 (Japanese Only)
  • 臨時報告書・有価証券届出書 (Japanese Only)
  • Annual Report
  • その他IR資料 (Japanese Only)
2024.03.22
Annual Report (January 1, 2023 through December 31, 2023)
2023.03.23
Annual Report (January 1, 2022 through December 31, 2022)
2022.03.29
Annual Report (January 1, 2021 through December 31, 2021)
2021.03.24
Annual Report (January 1, 2020 through December 31, 2020)
2020.03.26
Annual Report (January 1, 2019 through December 31, 2019)
2019.03.28
Annual Report (January 1, 2018 through December 31, 2018)
2018.03.13
Annual Report (January 1, 2017 through December 31, 2017)
2017.03.06
Annual Report (January 1, 2016 through December 31, 2016)
2016.03.11
Annual Report (January 1, 2015 through December 31, 2015)
2015.03.06
Annual Report (January 1, 2014 through December 31, 2014)
2014.03.07
Annual Report (January 1, 2013 through December 31, 2013)
2013.03.08
Annual Report (January 1, 2012 through December 31, 2012)
2012.03.09
Annual Report (From January 1, 2011 To December 31, 2011)

IR information

  • Latest IR information
  • IR news
  • CEO message
  • Financial highlights
  • IR library
  • Analyst report
  • Video library
  • IR Calendar
  • General Meeting of Shareholders Information
  • Basic stock information
  • Electronic public notice
  • シェアード・リサーチ
SymBio Pharmaceuticals
  • Inquiry
  • Contact Us for business opportunity
  • Personal information protection policy, etc.
  • Privacy Notice for Clinical Trials in UK
  • About the use of the site
  • site map
Copyright © SymBio Pharmaceuticals Limited. All rights reserved.